PMID: 11933130Apr 5, 2002Paper

Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency

Phytotherapy Research : PTR
Rainer Koch

Abstract

The aim of this study was to compare the efficacy of Venostasin (horse chestnut seed extract) and Pycnogenol (French maritime pine bark extract) in the treatment of chronic venous insufficiency (CVI). In an open, controlled comparative study 40 patients with diagnosed CVI were treated either with 600 mg chestnut seed extract per day or 360 mg Pycnogenol per day over a period of 4 weeks. The following parameters were investigated before the start of treatment and after 2 and 4 weeks of treatment: circumference of the lower legs and rating of subjective symptoms (scores) of pain, cramps, night-time swelling, feeling of "heaviness", and reddening of the skin. In addition, blood levels of cholesterol LDL and HDL were determined before and at the end of treatment. Pycnogenol significantly reduced the circumference of the lower limbs and significantly improved subjective symptoms. Furthermore, Pycnogenol significantly decreased cholesterol and LDL values in the blood, whereas HDL remained unaffected. Venostasin only moderately but not significantly, reduced the circumference of the lower limbs and marginally improved symptoms. Venostasin had no influence on the determined lipid values. Both medications were equally well tolerated. In...Continue Reading

References

Oct 1, 1991·The Journal of Dermatologic Surgery and Oncology·H Partsch
Feb 1, 1994·The British Journal of Surgery·M J Callam
Oct 22, 1998·Journal of Cardiovascular Pharmacology·D F FitzpatrickP Rohdewald
Sep 25, 1999·Thrombosis Research·M PütterP Rohdewald
Jun 14, 2000·Fitoterapia·P Arcangeli
Nov 18, 2000·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·C PetrassiC Spartera
Dec 21, 2004·Drug Development and Industrial Pharmacy·F VeigaM E Pina

❮ Previous
Next ❯

Citations

Aug 19, 2007·International Journal of Impotence Research·R StanislavovP Rohdewald
Aug 17, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Juliane ReuterChristoph Schempp
Jun 19, 2013·Phytotherapy Research : PTR·Om P Gulati
Dec 31, 2009·Phytotherapy Research : PTR·Gianni BelcaroPeter Rohdewald
Jan 24, 2015·Medical Hypotheses·Michael S Donaldson
Dec 14, 2006·Journal of Cosmetic Dermatology·C RonaE Berardesca
May 19, 2006·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·M R CesaroneM Corsi
Apr 20, 2012·The Cochrane Database of Systematic Reviews·Anel SchooneesJimmy Volmink
Aug 23, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Donald S NuzumSamir A Kouzi
Apr 7, 2016·The Cochrane Database of Systematic Reviews·Maria José Martinez-ZapataXavier Bonfill Cosp
Sep 30, 2020·The Cochrane Database of Systematic Reviews·Nina U RobertsonJanicke Visser
Jun 23, 2018·Journal of Neuroinflammation·Cailong PanYinbing Pan
Jul 28, 2019·Minerva cardioangiologica·Maria R CesaroneClaudia Maione
Dec 19, 2013·Journal of Cardiovascular Pharmacology and Therapeutics·Amirhossein Sahebkar
Nov 16, 2012·The Cochrane Database of Systematic Reviews·Max H Pittler, Edzard Ernst
Jun 4, 2013·The Cochrane Database of Systematic Reviews·Christopher ScallonZoriah Aziz
Oct 5, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Mahsa MalekahmadiSepideh Soltani
Jan 20, 2005·Journal of Agricultural and Food Chemistry·Claude-Alain CallisteJean-Luc Duroux

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.